SRPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.70%

Insider Buying (Last 12 Months): $4,955,684.40

Insider Selling (Last 12 Months): $10,672,909.13

Sarepta Therapeutics Insider Trading History Chart

Sarepta Therapeutics Share Price & Price History

^$62.40

▲ +1.55 (2.55%)

As of 04/30/2025 05:00 PM ET

Days: 30 | 90 | 365

Sarepta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/12/2025	Claude Nicaise	Director	Sell	2,491	$99.64	$248,203.24	27,812
12/12/2024	Hans Rudolf Wigzell	Director	Sell	10,500	$124.84	$1,310,820.00	22,840
12/5/2024	Kathryn Jean Boor	Director	Sell	1,636	$125.55	$205,399.80	5,880
8/30/2024	Ian Michael Estepan	CFO	Sell	5,985	$137.36	$822,099.60	33,946
8/16/2024	Michael Andrew Chambers	Director	Buy	37,038	$133.80	$4,955,684.40	284,034
6/25/2024	Ryan Edward Brown	EVP	Sell	38,957	$161.61	$6,295,840.77	17,129
6/24/2024	Bilal Arif	Insider	Sell	7,859	$163.08	$1,281,645.72	21,261
5/2/2024	Dallan Murray	Insider	Sell	3,635	$140.00	$508,900.00	18,125
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73	7,516
3/8/2024	Hans Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00	22,840
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60	6,621
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00	26,836
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00	39,114
11/3/2023	Douglas S. Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00	390,307
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00	140,000
8/14/2023	Michael Andrew Chambers	Director	Buy	9,979	$109.47	$1,092,401.13	246,996
8/10/2023	Michael Andrew Chambers	Director	Buy	34,867	$106.15	$3,701,132.05	213,331
8/4/2023	Hans Rudolf Wigzell	Director	Sell	15,000	$106.72	$1,600,800.00	20,994
11/17/2022	Stephen Mayo	Director	Sell	858	$109.92	$94,311.36	6,387
9/14/2022	Michael Andrew Chambers	Director	Buy	57,100	$104.43	$5,962,953.00	108,178
8/19/2022	Michael Andrew Chambers	Director	Buy	46,170	$108.28	$4,999,287.60	51,078

See Full Table

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sarepta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/30/2025	State of Michigan Retirement System	22,900	$1.46M	0.0%	+1.3%	0.024%
4/30/2025	Nisa Investment Advisors LLC	1,150	$73K	0.0%	-12.7%	0.001%
4/30/2025	Banque Pictet & Cie SA	3,236	$0.21M	0.0%	-92.6%	0.003%
4/30/2025	Arcadia Investment Management Corp MI	7,815	$0.50M	0.1%	+12.7%	0.008%
4/30/2025	Linden Thomas Advisory Services LLC	11,809	$0.75M	0.1%	+5.6%	0.012%
4/30/2025	M&T Bank Corp	3,562	$0.23M	0.0%	-19.5%	0.004%
4/30/2025	China Universal Asset Management Co. Ltd.	19,463	$1.24M	0.1%	-3.9%	0.020%
4/29/2025	Envestnet Asset Management Inc.	37,359	$2.38M	0.0%	-18.1%	0.039%
4/29/2025	Quattro Financial Advisors LLC	7,000	$0.45M	0.2%	N/A	0.007%
4/29/2025	Braun Stacey Associates Inc.	65,857	$4.20M	0.2%	-34.2%	0.068%
4/29/2025	GF Fund Management CO. LTD.	2,446	$0.16M	0.0%	+21.9%	0.003%
4/28/2025	Principal Financial Group Inc.	244,766	$15.62M	0.0%	-13.2%	0.252%
4/28/2025	Teacher Retirement System of Texas	23,137	$1.48M	0.0%	-9.0%	0.024%
4/28/2025	WCM Investment Management LLC	22,664	$1.60M	0.0%	-1.4%	0.023%
4/25/2025	Peregrine Capital Management LLC	68,874	$4.40M	0.1%	+28.0%	0.071%
4/25/2025	New York State Teachers Retirement System	79,361	$5.07M	0.0%	+3.3%	0.082%
4/25/2025	Amalgamated Bank	44,959	$2.87M	0.0%	-3.7%	0.046%
4/25/2025	Sovran Advisors LLC	57,509	$3.67M	0.5%	+112.9%	0.059%
4/24/2025	Allspring Global Investments Holdings LLC	50,472	$3.13M	0.0%	-40.9%	0.052%
4/24/2025	Mirae Asset Global Investments Co. Ltd.	3,223	$0.23M	0.0%	-50.9%	0.003%
4/24/2025	Money Concepts Capital Corp	24,021	$1.53M	0.1%	-0.7%	0.025%
4/23/2025	Harbour Capital Advisors LLC	4,925	$0.29M	0.1%	N/A	0.005%
4/23/2025	Sava Infond d.o.o.	4,500	$0.29M	0.1%	+50.0%	0.005%
4/22/2025	Cambridge Investment Research Advisors Inc.	6,387	$0.41M	0.0%	+5.9%	0.007%
4/22/2025	Center for Financial Planning Inc.	490	$31K	0.0%	N/A	0.001%
4/22/2025	PFG Investments LLC	26,433	$1.69M	0.1%	-2.1%	0.027%
4/21/2025	State of Alaska Department of Revenue	11,175	$0.71M	0.0%	+2.6%	0.012%
4/17/2025	Janney Montgomery Scott LLC	12,861	$0.82M	0.0%	N/A	0.013%
4/17/2025	Exchange Traded Concepts LLC	7,500	$0.48M	0.0%	N/A	0.008%
4/16/2025	Byrne Asset Management LLC	469	$30K	0.0%	N/A	0.000%
4/16/2025	Wealth Enhancement Advisory Services LLC	4,365	$0.28M	0.0%	-7.1%	0.004%
4/16/2025	Tobam	37,808	$2.41M	1.0%	+30.7%	0.039%
4/15/2025	Fifth Third Bancorp	448	$29K	0.0%	-75.5%	0.000%
4/15/2025	Assenagon Asset Management S.A.	712,581	$45.48M	0.1%	+438.0%	0.734%
4/15/2025	GAMMA Investing LLC	640	$41K	0.0%	-25.1%	0.001%
4/14/2025	Yousif Capital Management LLC	28,783	$1.84M	0.0%	-2.8%	0.030%
4/14/2025	Harbor Capital Advisors Inc.	456	$29K	0.0%	-73.3%	0.000%
4/14/2025	UMB Bank n.a.	797	$51K	0.0%	+53.0%	0.001%
4/8/2025	Rhumbline Advisers	265,244	$16.93M	0.0%	-1.0%	0.273%
4/7/2025	GAMMA Investing LLC	40,845	$2.61M	0.0%	+4,682.8%	0.042%
3/18/2025	California State Teachers Retirement System	80,662	$9.81M	0.0%	-0.3%	0.083%
3/17/2025	Wealth Enhancement Advisory Services LLC	4,699	$0.57M	0.0%	+4.9%	0.005%
2/25/2025	Polar Asset Management Partners Inc.	10,000	$1.22M	0.0%	-21.3%	0.010%
2/20/2025	Mackenzie Financial Corp	23,262	$2.83M	0.0%	-28.4%	0.024%
2/19/2025	GF Fund Management CO. LTD.	2,006	$0.24M	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	31,110	$3.78M	0.0%	-5.4%	0.033%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	299,301	$36.39M	0.0%	+11.6%	0.313%
2/17/2025	Woodline Partners LP	46,986	$5.71M	0.0%	N/A	0.049%
2/17/2025	Vestal Point Capital LP	250,000	$30.40M	1.8%	N/A	0.262%
2/17/2025	Vident Advisory LLC	2,933	$0.36M	0.0%	N/A	0.003%
2/17/2025	Triglav Skladi D.O.O.	11,000	$1.34M	0.1%	N/A	0.012%
2/17/2025	Two Sigma Investments LP	75,054	$9.13M	0.0%	-62.9%	0.079%
2/17/2025	Tidal Investments LLC	2,972	$0.36M	0.0%	-47.2%	0.003%
2/17/2025	Tema Etfs LLC	1,943	$0.24M	0.1%	N/A	0.002%
2/17/2025	Thornburg Investment Management Inc.	38,984	$4.74M	0.1%	-1.2%	0.041%
2/17/2025	Summit Partners Public Asset Management LLC	379,150	$46.10M	0.9%	+174.5%	0.397%
2/17/2025	Suvretta Capital Management LLC	17,888	$2.18M	0.1%	N/A	0.019%
2/17/2025	Sphera Funds Management LTD.	98,921	$12.03M	2.2%	-22.0%	0.104%
2/17/2025	Rafferty Asset Management LLC	109,236	$13.28M	0.0%	-20.9%	0.114%
2/17/2025	Raiffeisen Bank International AG	1,465	$0.18M	0.0%	N/A	0.002%
2/17/2025	Polar Asset Management Partners Inc.	10,000	$1.22M	0.0%	-21.3%	0.010%
2/17/2025	ProShare Advisors LLC	8,994	$1.09M	0.0%	-8.2%	0.009%
2/17/2025	Main Management ETF Advisors LLC	4,984	$0.61M	0.0%	-8.2%	0.005%
2/17/2025	Nuveen Asset Management LLC	524,579	$63.78M	0.0%	+10.6%	0.549%
2/17/2025	Orbimed Advisors LLC	963,400	$117.14M	2.6%	-4.1%	1.009%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	30,232	$3.67M	0.0%	-2.6%	0.032%
2/17/2025	LMR Partners LLP	3,724	$0.45M	0.0%	-173.4%	0.004%
2/17/2025	Logan Capital Management Inc.	500	$61K	0.0%	N/A	0.001%
2/17/2025	Lighthouse Investment Partners LLC	2,446	$0.30M	0.0%	-112.9%	0.003%
2/17/2025	J. Goldman & Co LP	87,866	$10.68M	0.3%	+10.9%	0.092%
2/17/2025	Janus Henderson Group PLC	4,328,323	$526.20M	0.3%	-0.7%	4.531%
2/17/2025	Guardian Wealth Advisors LLC NC	2,004	$0.24M	0.0%	N/A	0.002%
2/17/2025	Focus Partners Wealth	2,275	$0.28M	0.0%	+30.0%	0.002%
2/17/2025	Ensign Peak Advisors Inc	173,491	$21.10M	0.0%	-23.0%	0.182%
2/17/2025	Farallon Capital Management LLC	2,865,100	$348.37M	1.8%	+11.1%	2.999%
2/17/2025	Frontier Capital Management Co. LLC	35,562	$4.32M	0.0%	-11.8%	0.037%
2/17/2025	Fred Alger Management LLC	269,112	$32.72M	0.2%	-6.2%	0.282%
2/17/2025	D. E. Shaw & Co. Inc.	3,500	$0.43M	0.0%	-100.0%	0.004%
2/17/2025	EP Wealth Advisors LLC	4,988	$0.61M	0.0%	+2.2%	0.005%
2/17/2025	Crestline Management LP	33,893	$4.12M	0.1%	N/A	0.035%
2/17/2025	Cutter Capital Management LP	124,256	$15.11M	6.2%	+48.4%	0.130%
2/17/2025	Cetera Investment Advisers	11,174	$1.36M	0.0%	+4.3%	0.012%
2/17/2025	BOKF NA	11,992	$1.50M	0.0%	+599,500.0%	0.013%
2/17/2025	Braidwell LP	364,900	$44.37M	1.3%	-1.5%	0.382%
2/17/2025	Brevan Howard Capital Management LP	4,985	$0.61M	0.0%	+36.7%	0.005%
2/17/2025	Cantor Fitzgerald L. P.	1,750	$0.21M	0.0%	N/A	0.002%
2/17/2025	Captrust Financial Advisors	4,468	$0.54M	0.0%	+15.4%	0.005%
2/17/2025	Balyasny Asset Management L.P.	165,973	$20.18M	0.0%	-56.8%	0.174%
2/17/2025	Baldwin Investment Management LLC	2,000	$0.24M	0.0%	-11.1%	0.002%
2/17/2025	Bellevue Group AG	171,317	$20.83M	0.4%	-50.2%	0.179%
2/17/2025	Algert Global LLC	74,984	$9.12M	0.2%	+8.3%	0.079%
2/17/2025	Alkeon Capital Management LLC	853,845	$103.82M	0.2%	+34.7%	0.894%
2/17/2025	Alyeska Investment Group L.P.	24,997	$3.04M	0.0%	-89.4%	0.026%
2/17/2025	Aptus Capital Advisors LLC	2,327	$0.28M	0.0%	N/A	0.002%
2/17/2025	683 Capital Management LLC	102,000	$12.40M	0.8%	+16.9%	0.107%
2/14/2025	Mercer Global Advisors Inc. ADV	1,897	$0.23M	0.0%	-39.3%	0.002%
2/14/2025	Caisse DE Depot ET Placement DU Quebec	19,000	$2.31M	0.0%	N/A	0.020%
2/14/2025	One68 Global Capital LLC	2,000	$0.24M	0.1%	N/A	0.002%
2/14/2025	Comerica Bank	28,464	$3.46M	0.0%	-5.7%	0.030%
2/14/2025	Soros Fund Management LLC	230,893	$28.07M	0.4%	+11.8%	0.242%

Data available starting January 2016

See Full Table

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $62.40

$59.62

$62.51

50 Day Range

MA: $74.58

$49.30

$107.67

52 Week Range

Now: $62.40

$48.01

$173.25

Volume

1,576,742 shs

Average Volume

1,429,798 shs

Market Capitalization

$6.05 billion

P/E Ratio

49.92

Dividend Yield

N/A

Beta

0.93

Who are the company insiders with the largest holdings of Sarepta Therapeutics?: Sarepta Therapeutics' top insider investors include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Claude Nicaise (Director)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Ryan Edward Brown (EVP)
Kathryn Jean Boor (Director)
Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.
Who are the major institutional investors of Sarepta Therapeutics?: Sarepta Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.73%
Rhumbline Advisers — 0.27%
Principal Financial Group Inc. — 0.25%
New York State Teachers Retirement System — 0.08%
Peregrine Capital Management LLC — 0.07%
Braun Stacey Associates Inc. — 0.07%
Learn More about top institutional investors of Sarepta Therapeutics stock.
Which institutional investors are selling Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was sold by these institutional investors:
Principal Financial Group Inc.
Allspring Global Investments Holdings LLC
Braun Stacey Associates Inc.
Envestnet Asset Management Inc.
Mirae Asset Global Investments Co. Ltd.
Rhumbline Advisers
Teacher Retirement System of Texas
Amalgamated Bank
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Claude Nicaise (Director)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Learn More investors selling Sarepta Therapeutics stock.
Which institutional investors are buying Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was bought by institutional investors including:
Assenagon Asset Management S.A.
GAMMA Investing LLC
Sovran Advisors LLC
IMC Chicago LLC
Sivik Global Healthcare LLC
Peregrine Capital Management LLC
Janney Montgomery Scott LLC
Tobam
Within the last year, these company insiders have bought Sarepta Therapeutics stock:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Learn More investors buying Sarepta Therapeutics stock.